Chancity

Texas Life Science Forum 2026

A Houston forum bringing together life science ventures, investors, and leaders to discuss therapeutic and medtech innovation and commercialization.

Texas Medical Center Innovation, Houston

Date
November 10, 2026
Venue
Texas Medical Center Innovation, Houston

About

The program connects life science ventures with investors and leaders from industry and academia, with company presentations and discussion of financing and commercialization. The 2026 agenda lists speakers from research institutions, healthcare organizations, investment firms, and biotechnology companies.

Source: txlifescienceforum.org

Who you'll find in the room

Emerging life science ventures

The organizer identifies emerging life science ventures as part of the forum audience.

Investors

Investors are included in the organizer’s stated audience.

Industry and academic leaders

The organizer names industry and academic leaders among attendees.

Featured speakers

72 listed

Brad Burke

Associate Vice President, Industry & New Ventures, Rice Innovation, Ion

Executive Director, Rice Alliance for Technology and Entrepreneurship

William McKeon

President and CEO, Texas Medical Center

Patrick Clayton

Vice President, Life Sciences and Healthcare Startup Banking, J.P. Morgan

Annie Sendejo

Vice President, Life Sciences Banking, J.P. Morgan

Barbara Alcaraz Silva

Executive Director, Life Sciences and Healthcare Startup Banking, J.P. Morgan

Sean MacGregor

Executive Director, Healthcare Investment Banking, J.P. Morgan

Sarah Hein

Cofounder & CEO, March Biosciences

Suma Gopinathan

Senior Vice President, Discovery, Lexicon Pharmaceuticals (Nasdaq: LXRX)

Michael Torosian

Partner, Baker Botts

SingleCell Biotechnology

Company Presentation

Train Genomics

Company Presentation

Acuamark Diagnostics

Company Presentation

Alwayslab

Company Presentation

Emily Reiser

Strategy and New Ventures, Texas Medical Center

Bryson Saéz

Life Science - Investor Lead, HAN and Venture Partner, Novellus Ventures

Fred Shane

CEO, Axil Capital Advisors

Drew Yashar

Senior Associate, Life Sciences, Capital Factory

Pothik Chatterjee

Executive Director, Digital Health Institute, Rice University and Methodist Hospital

Khurram Nasir

Chief, Cardiovascular Prevention and Wellness, Houston Methodist Hospital, Co-Director, Houston Methodist-Rice Digital Health Institute, Professor of Medicine, Weill Cornell Medical College

Kristen Doyle

CEO, Cancer Prevention and Research Institute of Texas (CPRIT)

Ken Smith

Chief Product Development Officer, Cancer Prevention and Research Institute of Texas (CPRIT)

Victoria Ford

CEO, Texas Healthcare and Bioscience Institute

PHIOGEN

Company Presentation

Miracle Regeneratives

Company Presentation

NKILT Therapeutics

Company Presentation

InterAct Therapeutics

Company Presentation

Velvet Therapeutics

Company Presentation

Tomahawk Oncology

Company Presentation

Oncotherics

Company Presentation

IonTX

Company Presentation

PaxImmune Therapeutics

Company Presentation

OmniNano Pharmaceuticals

Company Presentation

Raymond Miller

Partner, U.S. Chair, Life Sciences Patent Development and Strategy, DLA Piper

Michael Dilling

Executive Director of Commercialization, BCM Innovation Institute

SageSpectra

Company Presentation

Cardiost

Company Presentation

Modulate Technologies

Company Presentation

Previze.AI

Company Presentation

OptiLung

Company Presentation

Freyya

Company Presentation

Joe Petrosino

Chief Scientific Innovation Officer, Baylor College of Medicine

Bruce Butler

Vice President, Research and Technology Director, Office of Technology Management, UT Health

Vineet Gupta

Vice President for Innovation & Tech Development & Transfer, UTMB

Emily Barnhill

Vice President, Strategic Industry Ventures, MD Anderson

Suzanne Tomlinson-Mathis

Director, Research Programs and Strategic Initiatives, Gulf Coast Consortia for Quantitative Biomedical Science

Verena Kallhoff

Sr. Director, Global Life Sciences, Greater Houston Partnership

Shawn Cloonan

Co-Life Science Lead and General Counsel, McCord Development

Chris Wild

Assistant Vice Chancellor/Vice President, San Jacinto College

Danielle Scheiner

Vice President, Regional Economic Development, Greater Houston Partnership

Bectas Therapeutics

Company Presentation

4M Therapeutics

Company Presentation

HydroGene Therapeutics

Company Presentation

ENB Therapeutics

Company Presentation

Ypsilon Tx

Company Presentation

Oticara

Company Presentation

CrossBridge Bio

Company Presentation

Circurna

Company Presentation

Scott Nudelman

Co-founder and Managing Principal, Vitrian

Donna Chang

CEO, Hope Biosciences

Federica Giordano

Director of Clinical Operations, March Biosciences

Ricardo Jimenez

SVP, Technical Operations, Neurogene

Laine Linden

Head of Technical Operations, CTMC

Allterum Therapeutics

Company Presentation

7 Hills Pharma

Company Presentation

Persevere Therapeutics

Company Presentation

PINOVA Therapeutics

Company Presentation

Orphagen Pharmaceuticals

Company Presentation

Iterion Therapeutics

Company Presentation

Indapta Therapeutics

Company Presentation

Medley Therapeutics

Company Presentation

Bob Radinsky

Vice President, Global Head, Oncology External Innovation, Johnson & Johnson

Partners on record

3 listed
InsperitySponsored byAustin Community College Bioscience IncubatorSponsored byVinson & ElkinsSponsored by

Venue & travel

Venue

Texas Medical Center Innovation

Questions people ask

5 answered

Texas Life Science Forum 2026 starts on November 10, 2026.

The 2026 forum is held at Texas Medical Center Innovation in Houston.

The organizer identifies emerging life science ventures, investors, and industry and academic leaders as attendees.

It is most useful for early-stage therapeutic and medtech founders looking for investors, since the program includes company pitches from SingleCell Biotechnology, Train Genomics, Acuamark Diagnostics and Alwayslab, alongside bankers from J.P. Morgan and Michael Torosian, a Partner at Baker Botts. Scientists wanting deep technical content and established companies will get less from it, because the conversations center on commercializing, financing and scaling new ventures.

Attendees at biotech investor and startup forums usually wear business casual, such as slacks and a button-down or blazer, with founders pitching often a notch sharper.

Related events

Find more events with this kind of reach.

We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.

Also listed in